About this trial
A Prospective Follow-up Assessment in Bad Segeberg with Patients undergoing Recanalization for Coronary Chronic Total Occlusion Lesion/s
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with coronary chronic total occlusions undergoing recanalization via percutaneous coronary interventions
Disqualifiers
None
Trial population
Patients with coronary chronic total occlusions undergoing recanalization vie percutaneous coronary interventions
Trial design
Cohort
Prospective
Treatments tested in this trial
Revascularization/Conservative management
Procedure/SurgeryPercutaneous Transluminal Angioplasty of Coronary Chronic Total Occlusions via Dedicated Drug Eluting Stents and/or Balloons.
Treatment groups
Trial outcomes
Primary outcomes
Rate of in-hospital and long-term cardiovascular adverse events in percent
Peri-procedural events and in-hospital cardiovascular events and long-term cardiovascular events (bleeding, peripheral and coronary vascular complication, stroke, myocardial infarction, stent thrombosis, revascularization, death)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.